Myocardial fibrosis, the expansion of the cardiac interstitium through deposition of
extracellular matrix proteins, is a common pathophysiologic companion of many different …

Introduction: COVID-19 is causing considerable morbidity and mortality worldwide. Serious
respiratory complications aside, the heart is also frequently involved. The mechanisms and …

Objectives The purpose of this study was to investigate the effect of empagliflozin on
diastolic function in a nondiabetic heart failure with reduced ejection fraction (HFrEF) …

Background: Patients with left ventricular (LV) systolic dysfunction after myocardial infarction
are at a high risk of developing heart failure. The addition of neprilysin inhibition to renin …

Objective To investigate the prognostic significance of T1 mapping using T1 long and short
in hypertrophic cardiomyopathy (HCM) patients. Methods A total of 263 consecutive patients …

Introduction Elevated myocardial T 1-mapping and extracellular volume (ECV) measured on
cardiac MR (CMR) imaging is associated with myocardial abnormalities such as oedema or …

Objectives To explore the prognostic value of subclinical cardiovascular (CV) imaging
measures and serum cardiac biomarkers in systemic sclerosis (SSc) for the development of …

Objectives SSc primary heart involvement (SSc-pHI) is a significant cause of mortality. We
aimed to characterize and identify predictors of subclinical SSc-pHI using cardiovascular …

Background Cardiac fibrosis is the excessive deposition of extracellular matrix in the heart,
triggered by a cardiac insult, aging, genetics, or environmental factors. Molecular imaging of …

Background Myocardial fibrosis and left ventricular (LV) longitudinal strain are
independently associated with adverse clinical outcomes. However, the relationship …